Follow the Topic British Journal of Cancer This journal is devoted to publishing cutting edge discovery, translational and clinical cancer research across the broad spectrum of oncology.
PubMed Moffa S, Improta I, Rocchetti S, Mezza T, Giaccari A
Exenatide and liraglutide were released onto the market relatively early, whereas newer agents, such as lixisenatide, dulaglutide, and albiglutide, were approved more recently (Table 1)
Beyond the core signaling molecules, transcriptional regulation and neurodevelopment within this pathway are equally crucial
Several factors impact how quickly patients respond to GLP-1 medications: Starting weight Hormonal balance Metabolic rate Diet and physical activity Adherence to prescribed protocols Both journeys are valid and meaningful